Literature DB >> 23258649

Necessity of early intervention for IgG4-related disease--delayed treatment induces fibrosis progression.

Yui Shimizu1, Motohisa Yamamoto, Yasuyoshi Naishiro, Gohta Sudoh, Keisuke Ishigami, Hidetaka Yajima, Tetsuya Tabeya, Mikiko Matsui, Chisako Suzuki, Hiroki Takahashi, Nobuhiko Seki, Tetsuo Himi, Ken Yamashita, Hiroko Noguchi, Tadashi Hasegawa, Yasuo Suzuki, Saho Honda, Takashi Abe, Kohzoh Imai, Yasuhisa Shinomura.   

Abstract

OBJECTIVE: Despite ongoing research, the clinical and histopathological natural history of immunoglobulin (Ig) G4-related disease (IgG4-RD) remains unclear and the optimal time to initiate treatment is unknown. A focus on clinical symptoms rather than image finding is recommended for therapeutic initiation in autoimmune pancreatitis, but evidence for this approach is lacking. We aimed to retrospectively analyse disease duration, efficacy of treatment with glucocorticoids and results of histopathological examination of submandibular gland specimens to clarify the necessity for early intervention in IgG4-RD.
METHODS: Salivary secretions were assessed before and after treatment in 26 cases of IgG4-related Mikulicz's disease (IgG4-MD). Relationships between disease duration, amount of salivary secretion before treatment, improvement of salivary secretion and ratios of areas of residual acini, fibrosis and lymphoid follicles in the involved submandibular gland specimens were analysed.
RESULTS: Salivary secretions were significantly reduced in cases with illness of >2 years (P < 0.05). An inverse correlation was seen between improved amount of salivary secretion and amount of salivary secretion before treatment (r = -0.60). Improved amount of salivary secretion was also associated with each histological factor (acini, r = 0.29; fibrosis, r = -0.23; lymphoid follicles, r = -0.31), which showed interrelationships (acini and lymphoid follicles, r = -0.23; acini and fibrosis, r = 0.42; lymphoid follicles and fibrosis, r = 0.30).
CONCLUSION: Salivary secretion can be improved even in cases with lower levels of salivary secretion before treatment in IgG4-RD, but improvements in the amount of salivary secretion decrease with histological changes with delayed therapeutic intervention. These data suggest that early intervention is needed to improve outcomes in patients with IgG4-MD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23258649     DOI: 10.1093/rheumatology/kes358

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  16 in total

1.  Characterization and Comparison of Patient Subgroups Suspicious for IgG4-Related Disease and Malignant Lymphoma in Patients Followed-up for Sjögren's Syndrome.

Authors:  Antónia Szántó; Katalin Szabó; Gábor Nagy; Csaba Molnár; Margit Zeher
Journal:  Pathol Oncol Res       Date:  2016-01-19       Impact factor: 3.201

Review 2.  Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Yasuhisa Shinomura
Journal:  Nat Rev Rheumatol       Date:  2013-12-03       Impact factor: 20.543

Review 3.  An overview of the diagnosis and management of immunoglobulin G4-related disease.

Authors:  Debashis Haldar; Paul Cockwell; Alex G Richter; Keith J Roberts; Gideon M Hirschfield
Journal:  CMAJ       Date:  2016-06-20       Impact factor: 8.262

Review 4.  IgG4-Related Disease: Beyond Glucocorticoids.

Authors:  Mitsuhiro Akiyama; Tsutomu Takeuchi
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

5.  Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts.

Authors:  Hyon K Choi; John H Stone; Zachary S Wallace; Yuqing Zhang; Cory A Perugino; Ray Naden
Journal:  Ann Rheum Dis       Date:  2019-01-05       Impact factor: 19.103

6.  Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.

Authors:  Zachary S Wallace; Hamid Mattoo; Mollie Carruthers; Vinay S Mahajan; Emanuel Della Torre; Hang Lee; Maria Kulikova; Vikram Deshpande; Shiv Pillai; John H Stone
Journal:  Ann Rheum Dis       Date:  2014-05-09       Impact factor: 19.103

7.  Disruption of tight junction structure contributes to secretory dysfunction in IgG4-related sialadenitis.

Authors:  Sai-Nan Min; Li-Ling Wu; Yan-Yan Zhang; Wen-Xuan Zhu; Xin Cong; Guang-Yan Yu
Journal:  J Mol Histol       Date:  2019-12-21       Impact factor: 2.611

8.  Clinicopathological characteristics of immunoglobulin G4-related sialadenitis.

Authors:  Wei Li; Yan Chen; Zhi-Peng Sun; Zhi-Gang Cai; Tong-Tong Li; Lei Zhang; Min-Xian Huang; Hong Hua; Mei Li; Xia Hong; Jia-Zeng Su; Zhu-Yan Zhang; Yan-Ying Liu; Jing He; Zhan-Guo Li; Yan Gao; Guang-Yan Yu
Journal:  Arthritis Res Ther       Date:  2015-07-21       Impact factor: 5.156

Review 9.  IgG4-related disease: current challenges and future prospects.

Authors:  David Lang; Jochen Zwerina; Herwig Pieringer
Journal:  Ther Clin Risk Manag       Date:  2016-02-15       Impact factor: 2.423

Review 10.  IgG4-related disease involving vital organs diagnosed with lip biopsy: A case report and literature review.

Authors:  Mitsuhiro Akiyama; Yuko Kaneko; Yutaro Hayashi; Tsutomu Takeuchi
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.